PO76 - THE INCIDENCE OF QT INTERVAL PROLONGATION IN PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE METASTATIC BREAST CANCER TREATED WITH RIBOCICLIB COMBINED WITH ENDOCRINE THERAPY IN A REAL-WORLD SETTING

Autor: Kurbacher, Christian Martin, Kurbacher, A. Tabea, Schott, Alexander, Herz, Susanne, Kurbacher, Jutta Anna
Zdroj: In The Breast November 2019 48 Supplement 2:S50-S51
Databáze: ScienceDirect